Structure

InChI Key XCGSFFUVFURLIX-VFGNJEKYSA-N
Smile CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
InChI
InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C33H35N5O5
Molecular Weight 581.67
AlogP 1.99
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 4.0
Polar Surface Area 118.21
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 43.0

Pharmacology

Primary Target
5-HT1D receptor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hypotension, Orthostatic 1 D007024 ClinicalTrials

Related Entries

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 113-15-5
ChEBI 64318
ChEMBL CHEMBL442
DrugBank DB00696
DrugCentral 1043
EPA CompTox DTXSID9043774
FDA SRS PR834Q503T
Human Metabolome Database HMDB0014834
Guide to Pharmacology 149
PDB ERM
PharmGKB PA164747651
PubChem 8223
SureChEMBL SCHEMBL1483
ZINC ZINC000052955754